Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging

Proton magnetic resonance spectroscopy (1H-MRS) is evolving from single-volume localized acquisitions to multiple-volume acquisitions using magnetic resonance spectroscopic imaging (lH-MRSI). The normal regional patterns of 1H-MRSI-detectable metabolite signal intensities have yet to be established. We studied 13 healthy young adults with a multiple-section lH-MRSI technique. The metabolite signals measured were N-acetylaspartate (NA), cho-line-containing compounds (CHO), creatine-phosphocreatine (CRE), and lactate. Ten neuroanatomic regions (nine bilateral) were identified in gray matter, white matter, and basal nuclei. Analysis of the data led to the following conclusions: (1) NA and CHO signals from centrum semiovale (CSO) can be used as a normalizing factor to reduce intersub-ject variability due to external causes; (2) in normal human brain, there is no left versus right asymmetry in the regions studied; (3) statistically significant patterns of signal distribution of NA, CHO, and CRE can be identified in normal human brain; and (4) CSO-normalized metabolite signal intensities and metabolite ratios complement each other for the detection of significant regional differences.

[1]  A. Bizzi,et al.  Absolute Quantitation of Short TE Brain 1H‐MR Spectra and Spectroscopic Imaging Data , 1993, Journal of computer assisted tomography.

[2]  P. Bottomley,et al.  The trouble with spectroscopy papers , 1992, Journal of magnetic resonance imaging : JMRI.

[3]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  G. Sutherland,et al.  High‐Resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms , 1992, Magnetic resonance in medicine.

[5]  William H. Oldendorf,et al.  N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.

[6]  G. Fein,et al.  Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging , 1994, Annals of neurology.

[7]  H. Tallan.  Studies on the distribution of N-acetyl-L-aspartic acid in brain. , 1957, The Journal of biological chemistry.

[8]  M. A. Samphilipo,et al.  Quantitative proton spectroscopy of canine brain: in Vivo and in Vitro correlations , 1994, Magnetic resonance in medicine.

[9]  O Henriksen,et al.  In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. , 1993, Magnetic resonance imaging.

[10]  G B Matson,et al.  Human brain infarction: proton MR spectroscopy. , 1992, Radiology.

[11]  Der,et al.  Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. , 1990, Radiology.

[12]  J. Frahm,et al.  Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.

[13]  L. Brass,et al.  New anatomical and functional imaging methods , 1992, Annals of neurology.

[14]  J. Coyle,et al.  N‐Acetyl‐Aspartyl‐Glutamate: Regional Levels in Rat Brain and the Effects of Brain Lesions as Determined by a New HPLC Method , 1984, Journal of neurochemistry.

[15]  J. Hennig,et al.  Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy , 1992, NMR in biomedicine.

[16]  B. Miller.  A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[17]  P M Matthews,et al.  Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.

[18]  P M Matthews,et al.  Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques , 1992, Annals of neurology.

[19]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[20]  Raimo Sepponen,et al.  Book of Abstracts, Society of Magnetic Resonance in Medicine , 1993 .

[21]  P A Narayana,et al.  In vivo proton magnetic resonance spectroscopy studies of human brain. , 1991, Magnetic resonance imaging.

[22]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[23]  J. Cumings,et al.  Biochemistry and the Central Nervous System , 1967, Neurology.

[24]  Jullie W Pan,et al.  Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T , 1994, Magnetic resonance in medicine.

[25]  J H Duyn,et al.  Multisection proton MR spectroscopic imaging of the brain. , 1993, Radiology.

[26]  J. Olesen,et al.  Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis , 1991, Magnetic resonance in medicine.